Pediatric Intensive Care Unit, Schneider Children's Medical Center of Israel, Petach Tikva 49202, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Pediatric Hemato-Oncology, Schneider Children's Medical Center of Israel, Petach Tikva 49202, Israel; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
J Pediatr Surg. 2011 Apr;46(4):764-766. doi: 10.1016/j.jpedsurg.2011.01.009.
Thrombotic thrombocytopenic purpura is caused by an imbalance of von Willebrand factor and its cleaving protease, which leads to the formation of microthrombi in end-organs. It rarely occurs in the pediatric population. Plasma exchange can significantly reduce mortality and morbidity. We present a 14-month-old infant in whom clinical and laboratory abnormalities compatible with thrombotic thrombocytopenic purpura were noted several days after resection of a large pelvic tumor. Treatment with double volume plasma exchange on postoperative day 5 led to complete resolution of the renal failure, thrombocytopenia, anemia, and neurological manifestations. ADAMTS13 inhibitors were negative and no mutations were found in factor H, factor I, membrane cofactor protein, and thrombomodulin to account for genetic predisposition to thrombotic thrombocytopenic purpura or atypical hemolytic uremic syndrome. Postoperative anemia, thrombocytopenia, fever, and neurological deficits in children should raise the suspicion of thrombotic thrombocytopenic purpura. Early diagnosis is important because the disorder is readily and efficiently treated with plasma exchange.
血栓性血小板减少性紫癜是由于 von Willebrand 因子与其裂解蛋白酶之间的失衡引起的,导致终末器官中小血栓的形成。它在儿科人群中很少见。血浆置换可显著降低死亡率和发病率。我们报告了一例 14 个月大的婴儿,在切除大骨盆肿瘤后几天,出现了与血栓性血小板减少性紫癜相符的临床和实验室异常。术后第 5 天给予双倍容量的血浆置换治疗,导致肾衰竭、血小板减少、贫血和神经表现完全缓解。ADAMTS13 抑制剂为阴性,因子 H、因子 I、膜辅因子蛋白和血栓调节蛋白中未发现突变,无法解释血栓性血小板减少性紫癜或非典型溶血尿毒综合征的遗传易感性。儿童术后贫血、血小板减少、发热和神经功能缺损应引起对血栓性血小板减少性紫癜的怀疑。早期诊断很重要,因为该疾病可以通过血浆置换有效地治疗。